Clinical trial
Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor
NCT00070161 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00070161 |
|---|---|
| Title | Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor |
| Official title | Donepezil and EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Radiation Toxicity |
| Intervention type | Dietary Supplement, Drug, Procedure |
| Interventions | EGb761, donepezil hydrochloride, cognitive assessment |
| Enrollment | 68 |
| Start date | Jul 1, 2001 |
| Primary completion | May 1, 2005 |
| Completion | Aug 1, 2012 |
| First posted | Oct 7, 2003 |
| Last update posted | Sep 9, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: